FULC - Fulcrum Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FULC is currently covered by 5 analysts with an average price target of $12.22. This is a potential upside of $3.2 (35.48%) from yesterday's end of day stock price of $9.02.

Fulcrum Therapeutics's activity chart (see below) currently has 114 price targets and 84 ratings on display. The stock rating distribution of FULC is 37.5% HOLD and 62.5% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.7% with an average time for these price targets to be met of 150.92 days.

Highest price target for FULC is $16, Lowest price target is $4, average price target is $10.8.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 30-Oct-2025. First documented stock forecast 12-Aug-2019.

Currently out of the existing stock ratings of FULC, 3 are a HOLD (37.5%), 5 are a BUY (62.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$16

$7.25 (82.86%)

$9

5 days ago
(30-Oct-2025)

4/12 (33.33%)

$7.4 (86.05%)

159

Buy

$12

$3.25 (37.14%)

$4

3 months 6 days ago
(29-Jul-2025)

11/19 (57.89%)

$4.41 (58.10%)

129

Buy

$12

$3.25 (37.14%)

$4

5 months 12 days ago
(23-May-2025)

2/3 (66.67%)

$5.56 (86.34%)

184

Buy

$10

$1.25 (14.29%)

5 months 20 days ago
(15-May-2025)

1/3 (33.33%)

$3.4 (51.52%)

166

Hold

$4

$-4.75 (-54.29%)

$4

11 months 21 days ago
(14-Nov-2024)

2/3 (66.67%)

$0.68 (20.48%)

19

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FULC (Fulcrum Therapeutics) average time for price targets to be met?

On average it took 150.92 days on average for the stock forecasts to be realized with a an average price target met ratio 55.7

Which analyst has the current highest performing score on FULC (Fulcrum Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the most public recommendations on FULC (Fulcrum Therapeutics)?

Judah Frommer works at MORGAN STANLEY and has 7 price targets and 4 ratings on FULC

Which analyst is the currently most bullish on FULC (Fulcrum Therapeutics)?

Edward Tenthoff with highest potential upside - $7.25

Which analyst is the currently most reserved on FULC (Fulcrum Therapeutics)?

Tazeen Ahmad with lowest potential downside - -$6.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?